Ryan Arthur F, a director at Regeneron Pharmaceuticals ($REGN), made 26 open market sales of common shares over the past year, totaling $156,402. His most recent sale occurred on March 2, 2026. These transactions rank 8,905th among 11,678 insiders by sale value, well below the average of $8.6 million across about 6.4 sales per seller. He recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 14 | $775.58 | 17,669.0000 | 137,600,000 | 0.08% | 0.00% |
| April 1, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 8 | $774.58 | 17,683.0000 | 137,600,000 | 0.05% | 0.00% |
| April 1, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 8 | $773.59 | 17,691.0000 | 137,600,000 | 0.05% | 0.00% |
| April 1, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $772.76 | 17,699.0000 | 137,600,000 | 0.02% | 0.00% |
| April 1, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $771.32 | 17,702.0000 | 137,600,000 | 0.01% | 0.00% |
| April 1, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 40 | $779.71 | 17,603.0000 | 137,600,000 | 0.23% | 0.00% |
| April 1, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $778.24 | 17,643.0000 | 137,600,000 | 0.02% | 0.00% |
| April 1, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $777.42 | 17,647.0000 | 137,600,000 | 0.05% | 0.00% |
| April 1, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 13 | $776.62 | 17,656.0000 | 137,600,000 | 0.07% | 0.00% |
| March 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $777.46 | 17,796.0000 | 137,600,000 | 0.04% | 0.00% |
| March 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $778.30 | 17,794.0000 | 137,600,000 | 0.01% | 0.00% |
| March 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $782.62 | 17,782.0000 | 137,600,000 | 0.01% | 0.00% |
| March 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $780.69 | 17,786.0000 | 137,600,000 | 0.02% | 0.00% |
| March 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $781.21 | 17,784.0000 | 137,600,000 | 0.01% | 0.00% |
| March 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $779.69 | 17,789.0000 | 137,600,000 | 0.03% | 0.00% |
| March 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 20 | $789.28 | 17,703.0000 | 137,600,000 | 0.11% | 0.00% |
| March 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 20 | $788.96 | 17,723.0000 | 137,600,000 | 0.11% | 0.00% |
| March 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $787.34 | 17,743.0000 | 137,600,000 | 0.01% | 0.00% |
| March 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $786.61 | 17,745.0000 | 137,600,000 | 0.04% | 0.00% |
| March 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 11 | $785.48 | 17,752.0000 | 137,600,000 | 0.06% | 0.00% |
| March 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $784.48 | 17,763.0000 | 137,600,000 | 0.05% | 0.00% |
| March 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $783.62 | 17,772.0000 | 137,600,000 | 0.06% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $779.41 | 17,818.0000 | 137,600,000 | 0.03% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $775.63 | 17,902.0000 | 137,600,000 | 0.01% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $787.82 | 17,803.0000 | 137,600,000 | 0.01% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $786.29 | 17,804.0000 | 137,600,000 | 0.01% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $785.71 | 17,806.0000 | 137,600,000 | 0.01% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $784.59 | 17,807.0000 | 137,600,000 | 0.01% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $783.34 | 17,808.0000 | 137,600,000 | 0.02% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $782.53 | 17,811.0000 | 137,600,000 | 0.01% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $781.48 | 17,812.0000 | 137,600,000 | 0.03% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $780.09 | 17,817.0000 | 137,600,000 | 0.01% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 12 | $778.53 | 17,823.0000 | 137,600,000 | 0.07% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 57 | $777.56 | 17,835.0000 | 137,600,000 | 0.32% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $776.59 | 17,892.0000 | 137,600,000 | 0.06% | 0.00% |
| Jan. 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | A | Common Stock | 155 | $0.00 | 17,903.0000 | 137,600,000 | 0.87% | 0.00% |
| Jan. 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | A | Non-Qualified Stock Option (right to buy) | 1962 | $0.00 | 1,962.0000 | 137,600,000 | 9999.99% | 0.00% |
| Jan. 2, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | A | Non-Qualified Stock Option (right to buy) | 1958 | $0.00 | 1,958.0000 | 136,000,000 | 9999.99% | 0.00% |
| Jan. 2, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | A | Common Stock | 166 | $0.00 | 17,748.0000 | 136,000,000 | 0.94% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1041.35 | 17,679.0000 | 135,300,000 | 0.02% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1042.31 | 17,678.0000 | 135,300,000 | 0.01% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $1043.39 | 17,673.0000 | 135,300,000 | 0.03% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $1044.62 | 17,664.0000 | 135,300,000 | 0.05% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $1045.27 | 17,657.0000 | 135,300,000 | 0.04% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $1046.53 | 17,648.0000 | 135,300,000 | 0.05% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 12 | $1047.44 | 17,636.0000 | 135,300,000 | 0.07% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 12 | $1048.54 | 17,624.0000 | 135,300,000 | 0.07% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $1049.68 | 17,615.0000 | 135,300,000 | 0.05% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 6 | $1050.60 | 17,609.0000 | 135,300,000 | 0.03% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $1051.51 | 17,600.0000 | 135,300,000 | 0.05% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1052.44 | 17,596.0000 | 135,300,000 | 0.02% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $1057.38 | 17,584.0000 | 135,300,000 | 0.01% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1053.45 | 17,592.0000 | 135,300,000 | 0.02% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1054.90 | 17,589.0000 | 135,300,000 | 0.02% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1056.68 | 17,586.0000 | 135,300,000 | 0.02% | 0.00% |
| Oct. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $1059.28 | 17,582.0000 | 135,300,000 | 0.01% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 8 | $1174.32 | 17,745.0000 | 134,800,000 | 0.05% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1168.99 | 17,773.0000 | 134,800,000 | 0.02% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1170.40 | 17,769.0000 | 134,800,000 | 0.02% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 16 | $1172.75 | 17,753.0000 | 134,800,000 | 0.09% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 8 | $1175.66 | 17,737.0000 | 134,800,000 | 0.05% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1176.82 | 17,733.0000 | 134,800,000 | 0.02% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1177.73 | 17,729.0000 | 134,800,000 | 0.02% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1178.69 | 17,725.0000 | 134,800,000 | 0.02% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 8 | $1179.62 | 17,717.0000 | 134,800,000 | 0.05% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 8 | $1183.47 | 17,709.0000 | 134,800,000 | 0.05% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1184.26 | 17,708.0000 | 134,800,000 | 0.01% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1185.77 | 17,704.0000 | 134,800,000 | 0.02% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $1186.19 | 17,699.0000 | 134,800,000 | 0.03% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1187.95 | 17,696.0000 | 134,800,000 | 0.02% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1188.55 | 17,692.0000 | 134,800,000 | 0.02% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $1189.13 | 17,687.0000 | 134,800,000 | 0.03% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1190.00 | 17,686.0000 | 134,800,000 | 0.01% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1191.02 | 17,682.0000 | 134,800,000 | 0.02% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1166.52 | 17,778.0000 | 134,800,000 | 0.02% | 0.00% |
| Sept. 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1167.27 | 17,777.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1088.70 | 17,842.0000 | 134,800,000 | 0.02% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $1089.64 | 17,835.0000 | 134,800,000 | 0.04% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 11 | $1090.30 | 17,824.0000 | 134,800,000 | 0.06% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 13 | $1091.47 | 17,811.0000 | 134,800,000 | 0.07% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $1092.61 | 17,804.0000 | 134,800,000 | 0.04% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $1093.39 | 17,797.0000 | 134,800,000 | 0.04% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1094.02 | 17,796.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1095.35 | 17,793.0000 | 134,800,000 | 0.02% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1096.19 | 17,790.0000 | 134,800,000 | 0.02% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1097.69 | 17,787.0000 | 134,800,000 | 0.02% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1098.00 | 17,786.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1099.65 | 17,783.0000 | 134,800,000 | 0.02% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1058.90 | 17,880.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1062.71 | 17,879.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 6 | $1065.39 | 17,873.0000 | 134,800,000 | 0.03% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1066.33 | 17,869.0000 | 134,800,000 | 0.02% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1067.53 | 17,868.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1068.08 | 17,867.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1070.46 | 17,863.0000 | 134,800,000 | 0.02% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1073.03 | 17,862.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1074.34 | 17,861.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1076.07 | 17,858.0000 | 134,800,000 | 0.02% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1080.06 | 17,857.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1082.17 | 17,856.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1083.57 | 17,855.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1084.71 | 17,852.0000 | 134,800,000 | 0.02% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1100.03 | 17,782.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1053.22 | 17,881.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1085.71 | 17,849.0000 | 134,800,000 | 0.02% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $1086.38 | 17,847.0000 | 134,800,000 | 0.01% | 0.00% |
| Aug. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $1087.54 | 17,845.0000 | 134,800,000 | 0.01% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1047.11 | 17,979.0000 | 134,800,000 | 0.02% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $1050.87 | 17,977.0000 | 134,800,000 | 0.01% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $1051.58 | 17,970.0000 | 134,800,000 | 0.04% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 6 | $1052.19 | 17,964.0000 | 134,800,000 | 0.03% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1060.14 | 17,928.0000 | 134,800,000 | 0.02% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1061.73 | 17,925.0000 | 134,800,000 | 0.02% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 19 | $1062.31 | 17,906.0000 | 134,800,000 | 0.11% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $1063.87 | 17,901.0000 | 134,800,000 | 0.03% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $1064.55 | 17,894.0000 | 134,800,000 | 0.04% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1065.52 | 17,891.0000 | 134,800,000 | 0.02% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $1066.59 | 17,887.0000 | 134,800,000 | 0.02% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1067.51 | 17,884.0000 | 134,800,000 | 0.02% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $1068.09 | 17,882.0000 | 134,800,000 | 0.01% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $1057.64 | 17,951.0000 | 134,800,000 | 0.01% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 17 | $1058.49 | 17,934.0000 | 134,800,000 | 0.09% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $1059.36 | 17,931.0000 | 134,800,000 | 0.02% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $1056.81 | 17,953.0000 | 134,800,000 | 0.01% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $1054.25 | 17,955.0000 | 134,800,000 | 0.01% | 0.00% |
| July 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 8 | $1053.60 | 17,956.0000 | 134,800,000 | 0.04% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $1000.04 | 17,982.0000 | 134,199,999 | 0.03% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $979.40 | 18,080.0000 | 134,199,999 | 0.01% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $980.16 | 18,077.0000 | 134,199,999 | 0.02% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $981.95 | 18,074.0000 | 134,199,999 | 0.02% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $982.99 | 18,073.0000 | 134,199,999 | 0.01% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $984.52 | 18,071.0000 | 134,199,999 | 0.01% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $988.66 | 18,069.0000 | 134,199,999 | 0.01% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $990.74 | 18,065.0000 | 134,199,999 | 0.02% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $992.19 | 18,058.0000 | 134,199,999 | 0.04% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 12 | $993.20 | 18,046.0000 | 134,199,999 | 0.07% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $994.25 | 18,041.0000 | 134,199,999 | 0.03% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 6 | $995.76 | 18,035.0000 | 134,199,999 | 0.03% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 12 | $996.83 | 18,023.0000 | 134,199,999 | 0.07% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 15 | $997.76 | 18,008.0000 | 134,199,999 | 0.08% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 14 | $998.44 | 17,994.0000 | 134,199,999 | 0.08% | 0.00% |
| June 3, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $999.43 | 17,987.0000 | 134,199,999 | 0.04% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $891.52 | 18,170.0000 | 134,199,999 | 0.04% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $892.50 | 18,161.0000 | 134,199,999 | 0.05% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $893.16 | 18,156.0000 | 134,199,999 | 0.03% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $911.39 | 18,084.0000 | 134,199,999 | 0.02% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $895.38 | 18,154.0000 | 134,199,999 | 0.01% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $896.59 | 18,151.0000 | 134,199,999 | 0.02% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $897.68 | 18,142.0000 | 134,199,999 | 0.05% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $913.21 | 18,082.0000 | 134,199,999 | 0.01% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $912.29 | 18,083.0000 | 134,199,999 | 0.01% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 17 | $898.51 | 18,125.0000 | 134,199,999 | 0.09% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $899.37 | 18,118.0000 | 134,199,999 | 0.04% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $900.45 | 18,113.0000 | 134,199,999 | 0.03% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $901.41 | 18,109.0000 | 134,199,999 | 0.02% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $902.66 | 18,108.0000 | 134,199,999 | 0.01% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $903.35 | 18,107.0000 | 134,199,999 | 0.01% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $904.80 | 18,106.0000 | 134,199,999 | 0.01% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $905.50 | 18,104.0000 | 134,199,999 | 0.01% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $906.26 | 18,100.0000 | 134,199,999 | 0.02% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $907.54 | 18,098.0000 | 134,199,999 | 0.01% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $909.49 | 18,094.0000 | 134,199,999 | 0.02% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 6 | $910.47 | 18,088.0000 | 134,199,999 | 0.03% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $889.50 | 18,179.0000 | 134,199,999 | 0.02% | 0.00% |
| May 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $890.75 | 18,177.0000 | 134,199,999 | 0.01% | 0.00% |
| April 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 15 | $960.53 | 18,254.0000 | 134,199,999 | 0.08% | 0.00% |
| April 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 13 | $965.35 | 18,182.0000 | 134,199,999 | 0.07% | 0.00% |
| April 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 16 | $964.45 | 18,195.0000 | 134,199,999 | 0.09% | 0.00% |
| April 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 20 | $963.60 | 18,211.0000 | 134,199,999 | 0.11% | 0.00% |
| April 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $962.42 | 18,231.0000 | 134,199,999 | 0.05% | 0.00% |
| April 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 14 | $961.59 | 18,240.0000 | 134,199,999 | 0.08% | 0.00% |
| April 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $959.47 | 18,269.0000 | 134,199,999 | 0.05% | 0.00% |
| April 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $958.86 | 18,278.0000 | 134,199,999 | 0.01% | 0.00% |
| April 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $957.78 | 18,280.0000 | 134,199,999 | 0.01% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $972.29 | 18,372.0000 | 133,100,000 | 0.01% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $967.50 | 18,381.0000 | 133,100,000 | 0.01% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $968.66 | 18,380.0000 | 133,100,000 | 0.01% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $969.18 | 18,379.0000 | 133,100,000 | 0.01% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $970.38 | 18,375.0000 | 133,100,000 | 0.02% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $971.75 | 18,374.0000 | 133,100,000 | 0.01% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $988.30 | 18,282.0000 | 133,100,000 | 0.01% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $987.33 | 18,283.0000 | 133,100,000 | 0.02% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 8 | $986.58 | 18,287.0000 | 133,100,000 | 0.04% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $985.76 | 18,295.0000 | 133,100,000 | 0.05% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 19 | $984.45 | 18,305.0000 | 133,100,000 | 0.10% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 12 | $983.61 | 18,324.0000 | 133,100,000 | 0.07% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 11 | $982.67 | 18,336.0000 | 133,100,000 | 0.06% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 15 | $981.64 | 18,347.0000 | 133,100,000 | 0.08% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $980.21 | 18,362.0000 | 133,100,000 | 0.01% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $979.87 | 18,363.0000 | 133,100,000 | 0.01% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $978.09 | 18,364.0000 | 133,100,000 | 0.01% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $977.27 | 18,365.0000 | 133,100,000 | 0.01% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $976.81 | 18,367.0000 | 133,100,000 | 0.01% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $975.70 | 18,369.0000 | 133,100,000 | 0.01% | 0.00% |
| March 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $974.78 | 18,371.0000 | 133,100,000 | 0.01% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $953.18 | 18,444.0000 | 133,100,000 | 0.02% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $939.53 | 18,481.0000 | 133,100,000 | 0.01% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 6 | $941.91 | 18,475.0000 | 133,100,000 | 0.03% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $942.50 | 18,470.0000 | 133,100,000 | 0.03% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $943.54 | 18,467.0000 | 133,100,000 | 0.02% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $944.66 | 18,466.0000 | 133,100,000 | 0.01% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $947.37 | 18,463.0000 | 133,100,000 | 0.02% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $948.77 | 18,462.0000 | 133,100,000 | 0.01% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $949.48 | 18,452.0000 | 133,100,000 | 0.05% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $950.01 | 18,450.0000 | 133,100,000 | 0.01% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $951.40 | 18,447.0000 | 133,100,000 | 0.02% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $954.52 | 18,439.0000 | 133,100,000 | 0.03% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $955.35 | 18,429.0000 | 133,100,000 | 0.05% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $956.21 | 18,422.0000 | 133,100,000 | 0.04% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $957.75 | 18,419.0000 | 133,100,000 | 0.02% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $958.65 | 18,414.0000 | 133,100,000 | 0.03% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 8 | $959.68 | 18,406.0000 | 133,100,000 | 0.04% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $960.52 | 18,396.0000 | 133,100,000 | 0.05% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $961.37 | 18,392.0000 | 133,100,000 | 0.02% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 6 | $962.49 | 18,386.0000 | 133,100,000 | 0.03% | 0.00% |
| Feb. 1, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $963.73 | 18,382.0000 | 133,100,000 | 0.02% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 14 | $899.66 | 18,411.0000 | 133,100,000 | 0.08% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $873.91 | 18,446.0000 | 133,100,000 | 0.01% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $886.26 | 18,444.0000 | 133,100,000 | 0.01% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $887.13 | 18,443.0000 | 133,100,000 | 0.01% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $892.00 | 18,442.0000 | 133,100,000 | 0.01% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 8 | $896.47 | 18,434.0000 | 133,100,000 | 0.04% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $897.41 | 18,431.0000 | 133,100,000 | 0.02% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 6 | $898.76 | 18,425.0000 | 133,100,000 | 0.03% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | A | Non-Qualified Stock Option (right to buy) | 1607 | $0.00 | 1,607.0000 | 133,100,000 | 9999.99% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | A | Common Stock | 135 | $0.00 | 18,482.0000 | 133,100,000 | 0.74% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $904.49 | 18,347.0000 | 133,100,000 | 0.02% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 13 | $903.49 | 18,350.0000 | 133,100,000 | 0.07% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $902.37 | 18,363.0000 | 133,100,000 | 0.05% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $901.46 | 18,373.0000 | 133,100,000 | 0.05% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 29 | $900.59 | 18,382.0000 | 133,100,000 | 0.16% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $819.62 | 18,482.0000 | 130,400,000 | 0.04% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $821.92 | 18,471.0000 | 130,400,000 | 0.01% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $822.49 | 18,470.0000 | 130,400,000 | 0.01% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 6 | $823.36 | 18,464.0000 | 130,400,000 | 0.03% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $824.66 | 18,461.0000 | 130,400,000 | 0.02% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $825.38 | 18,459.0000 | 130,400,000 | 0.01% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $826.62 | 18,449.0000 | 130,400,000 | 0.05% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $827.61 | 18,447.0000 | 130,400,000 | 0.01% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $812.58 | 18,509.0000 | 130,400,000 | 0.02% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $813.35 | 18,505.0000 | 130,400,000 | 0.02% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $814.78 | 18,504.0000 | 130,400,000 | 0.01% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $815.46 | 18,501.0000 | 130,400,000 | 0.02% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $816.52 | 18,497.0000 | 130,400,000 | 0.02% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 6 | $817.52 | 18,491.0000 | 130,400,000 | 0.03% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $818.76 | 18,489.0000 | 130,400,000 | 0.01% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $820.50 | 18,473.0000 | 130,400,000 | 0.05% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $809.03 | 18,546.0000 | 130,400,000 | 0.01% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $810.77 | 18,539.0000 | 130,400,000 | 0.04% | 0.00% |
| Dec. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 27 | $811.48 | 18,512.0000 | 130,400,000 | 0.15% | 0.00% |
| Nov. 7, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 11 | $827.65 | 18,608.0000 | 130,400,000 | 0.06% | 0.00% |
| Nov. 7, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 18 | $829.43 | 18,551.0000 | 130,400,000 | 0.10% | 0.00% |
| Nov. 7, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 39 | $828.54 | 18,569.0000 | 130,400,000 | 0.21% | 0.00% |
| Nov. 7, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $838.46 | 18,547.0000 | 130,400,000 | 0.01% | 0.00% |
| Nov. 7, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $830.39 | 18,548.0000 | 130,400,000 | 0.02% | 0.00% |
| Nov. 7, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $826.58 | 18,619.0000 | 130,400,000 | 0.02% | 0.00% |
| Nov. 7, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 18 | $825.53 | 18,623.0000 | 130,400,000 | 0.10% | 0.00% |
| Nov. 7, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 6 | $824.59 | 18,641.0000 | 130,400,000 | 0.03% | 0.00% |
| Aug. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $744.66 | 18,647.0000 | 130,400,000 | 0.01% | 0.00% |
| Aug. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $732.76 | 18,745.0000 | 130,400,000 | 0.01% | 0.00% |
| Aug. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $733.51 | 18,741.0000 | 130,400,000 | 0.02% | 0.00% |
| Aug. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 18 | $734.56 | 18,723.0000 | 130,400,000 | 0.10% | 0.00% |
| Aug. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 22 | $735.55 | 18,701.0000 | 130,400,000 | 0.12% | 0.00% |
| Aug. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 16 | $736.64 | 18,685.0000 | 130,400,000 | 0.09% | 0.00% |
| Aug. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 17 | $737.50 | 18,668.0000 | 130,400,000 | 0.09% | 0.00% |
| Aug. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $738.45 | 18,658.0000 | 130,400,000 | 0.05% | 0.00% |
| Aug. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $739.63 | 18,653.0000 | 130,400,000 | 0.03% | 0.00% |
| Aug. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $740.52 | 18,650.0000 | 130,400,000 | 0.02% | 0.00% |
| Aug. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $741.42 | 18,648.0000 | 130,400,000 | 0.01% | 0.00% |
| July 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $720.15 | 18,747.0000 | 130,400,000 | 0.01% | 0.00% |
| July 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $710.09 | 18,846.0000 | 130,400,000 | 0.01% | 0.00% |
| July 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $711.95 | 18,845.0000 | 130,400,000 | 0.01% | 0.00% |
| July 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 6 | $713.82 | 18,839.0000 | 130,400,000 | 0.03% | 0.00% |
| July 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $714.65 | 18,829.0000 | 130,400,000 | 0.05% | 0.00% |
| July 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $715.23 | 18,822.0000 | 130,400,000 | 0.04% | 0.00% |
| July 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 29 | $716.74 | 18,793.0000 | 130,400,000 | 0.15% | 0.00% |
| July 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 22 | $717.57 | 18,771.0000 | 130,400,000 | 0.12% | 0.00% |
| July 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 12 | $718.71 | 18,759.0000 | 130,400,000 | 0.06% | 0.00% |
| July 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 11 | $719.36 | 18,748.0000 | 130,400,000 | 0.06% | 0.00% |
| June 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 17 | $737.52 | 18,854.0000 | 130,400,000 | 0.09% | 0.00% |
| June 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $730.03 | 18,945.0000 | 130,400,000 | 0.01% | 0.00% |
| June 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $731.49 | 18,936.0000 | 130,400,000 | 0.05% | 0.00% |
| June 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $732.49 | 18,926.0000 | 130,400,000 | 0.05% | 0.00% |
| June 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $733.61 | 18,924.0000 | 130,400,000 | 0.01% | 0.00% |
| June 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $734.62 | 18,914.0000 | 130,400,000 | 0.05% | 0.00% |
| June 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 12 | $735.42 | 18,902.0000 | 130,400,000 | 0.06% | 0.00% |
| June 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 31 | $736.40 | 18,871.0000 | 130,400,000 | 0.16% | 0.00% |
| June 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $738.35 | 18,847.0000 | 130,400,000 | 0.04% | 0.00% |
| May 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 17 | $807.50 | 18,962.0000 | 130,400,000 | 0.09% | 0.00% |
| May 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 16 | $802.67 | 19,031.0000 | 130,400,000 | 0.08% | 0.00% |
| May 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 30 | $803.58 | 19,001.0000 | 130,400,000 | 0.16% | 0.00% |
| May 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $804.51 | 18,999.0000 | 130,400,000 | 0.01% | 0.00% |
| May 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $805.34 | 18,994.0000 | 130,400,000 | 0.03% | 0.00% |
| May 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 15 | $806.53 | 18,979.0000 | 130,400,000 | 0.08% | 0.00% |
| May 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 15 | $808.11 | 18,947.0000 | 130,400,000 | 0.08% | 0.00% |
| April 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 6 | $823.34 | 19,047.0000 | 130,400,000 | 0.03% | 0.00% |
| April 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $822.37 | 19,053.0000 | 130,400,000 | 0.05% | 0.00% |
| April 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $821.61 | 19,062.0000 | 130,400,000 | 0.01% | 0.00% |
| April 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $820.55 | 19,063.0000 | 130,400,000 | 0.03% | 0.00% |
| April 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 32 | $819.48 | 19,068.0000 | 130,400,000 | 0.17% | 0.00% |
| April 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 27 | $818.47 | 19,100.0000 | 130,400,000 | 0.14% | 0.00% |
| April 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 13 | $817.49 | 19,127.0000 | 130,400,000 | 0.07% | 0.00% |
| April 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $816.58 | 19,140.0000 | 130,400,000 | 0.04% | 0.00% |
| March 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 16 | $761.62 | 19,201.0000 | 130,400,000 | 0.08% | 0.00% |
| March 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $766.32 | 19,147.0000 | 130,400,000 | 0.04% | 0.00% |
| March 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $765.55 | 19,154.0000 | 130,400,000 | 0.05% | 0.00% |
| March 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 17 | $764.49 | 19,164.0000 | 130,400,000 | 0.09% | 0.00% |
| March 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 11 | $763.51 | 19,181.0000 | 130,400,000 | 0.06% | 0.00% |
| March 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $762.28 | 19,192.0000 | 130,400,000 | 0.05% | 0.00% |
| March 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $760.54 | 19,217.0000 | 130,400,000 | 0.05% | 0.00% |
| March 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 15 | $759.48 | 19,227.0000 | 130,400,000 | 0.08% | 0.00% |
| March 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $758.20 | 19,242.0000 | 130,400,000 | 0.03% | 0.00% |
| Feb. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $757.29 | 19,267.0000 | 130,400,000 | 0.01% | 0.00% |
| Feb. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 24 | $756.77 | 19,269.0000 | 130,400,000 | 0.12% | 0.00% |
| Feb. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 17 | $755.50 | 19,293.0000 | 130,400,000 | 0.09% | 0.00% |
| Feb. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 18 | $753.54 | 19,327.0000 | 130,400,000 | 0.09% | 0.00% |
| Feb. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $752.11 | 19,345.0000 | 130,400,000 | 0.01% | 0.00% |
| Feb. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 17 | $754.45 | 19,310.0000 | 130,400,000 | 0.09% | 0.00% |
| Feb. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $762.17 | 19,247.0000 | 130,400,000 | 0.01% | 0.00% |
| Feb. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 3 | $761.58 | 19,249.0000 | 130,400,000 | 0.02% | 0.00% |
| Feb. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $760.40 | 19,252.0000 | 130,400,000 | 0.02% | 0.00% |
| Feb. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $759.65 | 19,256.0000 | 130,400,000 | 0.02% | 0.00% |
| Feb. 1, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 7 | $758.58 | 19,260.0000 | 130,400,000 | 0.04% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | A | Common Stock | 165 | $0.00 | 19,347.0000 | 130,400,000 | 0.86% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | A | Non-Qualified Stock Option (right to buy) | 1929 | $0.00 | 1,929.0000 | 130,400,000 | 9999.99% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 1 | $729.92 | 19,200.0000 | 130,400,000 | 0.01% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 4 | $730.35 | 19,196.0000 | 130,400,000 | 0.02% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 11 | $728.34 | 19,201.0000 | 130,400,000 | 0.06% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 13 | $727.59 | 19,212.0000 | 130,400,000 | 0.07% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $726.34 | 19,225.0000 | 130,400,000 | 0.05% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $725.63 | 19,235.0000 | 130,400,000 | 0.05% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 9 | $724.52 | 19,244.0000 | 130,400,000 | 0.05% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 10 | $723.52 | 19,253.0000 | 130,400,000 | 0.05% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 5 | $722.59 | 19,263.0000 | 130,400,000 | 0.03% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 14 | $721.48 | 19,268.0000 | 130,400,000 | 0.07% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 12 | $731.59 | 19,184.0000 | 130,400,000 | 0.06% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | RYAN ARTHUR F | Director | S | Common Stock | 2 | $732.18 | 19,182.0000 | 130,400,000 | 0.01% | 0.00% |